OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 141 filers reported holding OCULAR THERAPEUTIX INC in Q4 2021. The put-call ratio across all filers is 1.20 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $979,000 | -29.5% | 97,915 | 0.0% | 0.03% | -32.5% |
| Q2 2021 | $1,388,000 | -13.6% | 97,915 | 0.0% | 0.04% | -21.6% |
| Q1 2021 | $1,607,000 | -20.6% | 97,915 | +0.2% | 0.05% | -26.1% |
| Q4 2020 | $2,023,000 | +171.5% | 97,740 | -0.2% | 0.07% | +137.9% |
| Q3 2020 | $745,000 | -12.6% | 97,940 | -4.2% | 0.03% | -31.0% |
| Q2 2020 | $852,000 | +68.4% | 102,228 | 0.0% | 0.04% | +27.3% |
| Q1 2020 | $506,000 | +19.6% | 102,228 | -4.5% | 0.03% | +32.0% |
| Q4 2019 | $423,000 | – | 107,101 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,932,607 | $40,643,000 | 15.56% |
| Lamond Capital Partners LLC | 711,533 | $14,964,000 | 15.19% |
| Polaris Venture Management Co. V, L.L.C. | 1,230,009 | $25,867,000 | 11.54% |
| NOTTINGHAM ADVISORS, INC. | 171,985 | $3,617,000 | 0.60% |
| Portolan Capital Management | 122,518 | $2,577,000 | 0.36% |
| SPHERA FUNDS MANAGEMENT LTD. | 160,000 | $3,365,000 | 0.33% |
| Rotella Capital Management, Inc. | 18,461 | $388,000 | 0.32% |
| Monashee Investment Management LLC | 28,834 | $606,000 | 0.29% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 335,498 | $7,056,000 | 0.24% |
| BAILARD, INC. | 55,000 | $1,157,000 | 0.18% |